Live prices from 2 UK suppliers, from £45.00, compared side by side so you never overpay.
Copy the code — you'll paste it at checkout.
with our exclusive code
You're about to visit an external supplier
with our exclusive code
By clicking "Continue", you acknowledge that you understand and accept the above. Read our full disclosure.
Compare 1 price for Bronchogen. Cheapest: £45.00. Average: £45.00.
| Compare | Visit | |||||||
|---|---|---|---|---|---|---|---|---|
| £45.00 | £1.50/mg | Out of Stock | Free |
—
|
— |
More ways to compare Bronchogen
Different views of the same live UK pricing, tuned for how you like to shop.
Compare another peptide
All purchases are made directly from third-party suppliers; your relationship is solely with them. We accept no liability for the quality, purity, or legality of any products listed.
We may earn a commission when you click through to a supplier and make a purchase. This does not affect pricing information displayed.
By using this site you accept responsibility for ensuring purchases comply with applicable laws in your jurisdiction. Read our full disclosure.
AEDL Tetrapeptide | Bronchial Bioregulator
Bronchogen is a Khavinson bioregulator tetrapeptide (AEDL) with primary effects on the bronchopulmonary system. Developed at Russia's St. Petersburg Institute of Bioregulation and Gerontology by Professor Vladimir Khavinson, it targets bronchial tissue and supports respiratory function. Like other Khavinson peptides, Bronchogen penetrates cell nuclei to influence gene expression related to respiratory tissue maintenance and repair.
Bronchogen works through epigenetic regulation by penetrating cell and nuclear membranes to interact with DNA and modulate gene expression in bronchial tissue. It regulates protein synthesis in bronchopulmonary cells, supporting maintenance and repair of respiratory epithelium. The tetrapeptide structure allows efficient cellular uptake and tissue-specific targeting to bronchial structures.
AEDL
Alanine
Position 1
Glutamic Acid
Position 2
Aspartic Acid
Position 3
Leucine
Position 4
Supports bronchial tissue through gene expression regulation.
Helps maintain respiratory epithelium health.
Regulates protein synthesis in lung tissue.
Addresses age-related changes in bronchial tissue.
Modulates gene expression in respiratory cells.
Available in capsule form for oral administration. Short peptides can be absorbed orally and reach target tissues. Typical protocol involves 10-20 day cycles.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Standard protocol | 10-20 mg | Daily for 10-20 days | Oral capsules |
| Maintenance | 10 mg | 2-3 cycles yearly | Oral capsules |
Injectable form available for direct administration.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Research protocol | 10 mg | Daily for 10 days | IM or SubQ |
Related respiratory bioregulators; complementary mechanisms.
Often combined in comprehensive anti-aging Khavinson protocols.
Both have immune-modulating properties; different tissue targets.
Part of Khavinson bioregulator family; targets different tissue.
Gene expression modulation begins
Effects persist due to epigenetic changes
Respiratory function improvements
Cumulative benefits with periodic cycles
Advances in Gerontology
Comprehensive review of bioregulator peptides including respiratory bioregulators.
Bulletin of Experimental Biology and Medicine
Tetrapeptides derived from bronchial tissue regulate protein synthesis in respiratory cells.
Cell Technologies in Biology and Medicine
Short peptides support bronchopulmonary system through epigenetic mechanisms.
Be the first to know when prices drop on your favourite peptides
No spam. Unsubscribe anytime. We respect your privacy.